Abstract
Vaccine-preventable diseases are a major cause of morbidity in immunocompromised patients. This article reviews the data on efficacy and safety of currently licensed vaccines in patients with rheumatologic diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 567-584 |
Number of pages | 18 |
Journal | Rheumatic Disease Clinics of North America |
Volume | 25 |
Issue number | 3 |
DOIs | |
State | Published - 1999 |
Externally published | Yes |
ASJC Scopus subject areas
- Rheumatology